Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study Of Enadenotucirev Administered by Sub-Acute Fractionated Intravenous Injection: Dose Escalation in Metastatic Epithelial Solid Tumours and Randomised Controlled Trial in Metastatic Colorectal Cancer

NCT02028442 is registered in ClinicalTrials.gov with Akamis Bio as lead sponsor.

NCT NCT02028442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02028442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study Of Enadenotucirev Administered by Sub-Acute Fractionated Intravenous Injection: Dose Escalation in Metastatic Epithelial Solid Tumours and Randomised Controlled Trial in Metastatic Colorectal Cancer
Lead sponsor
Akamis Bio
Phase
Phase 1/2
Overall status
Completed
Start date
September 20, 2012
Completion date
April 29, 2016
Enrollment
61 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic bladder cancer, metastatic colorectal cancer, solid tumours of epithelial origin